BIOPROGNOSTIC

WIPO WIPO 2022

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke BIOPROGNOSTIC wurde als Wortmarke am 11.01.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 13. Juni 2023

Markenform Wortmarke
Aktenzeichen 1658287
Länder Australien Brasilien Kanada Schweiz China Kolumbien Europäische Gemeinschaft Großbritannien Israel Indien Japan Südkorea Mexiko Norwegen Neuseeland Russland Singapur
Basismarke US Nr. , 19. Juli 2024
Anmeldedatum 11. Januar 2022
Ablaufdatum 11. Januar 2032

Markeninhaber

1460 Broadway
New York NY 10036
US

Markenvertreter

1299 Pennsylvania Ave., NW, Suite 700 Washington DC 20004 US

Waren und Dienstleistungen

05 Medical diagnostic blood testing reagents and assays for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in kidney, heart, and liver health testing and disease prediction
10 Blood test collection kit comprised of blood collection bag, holder for medical sample tubes, vials, and test trips, and medical sample tubes, vials, and test strips for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health
42 Development of new technology for others in the field of medical devices and medical diagnostic apparatuses for predicting, identifying and determining the presence and stage of kidney, heart, and liver diseases and kidney, heart, and liver health; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney, heart, and liver health and kidney, heart, and liver diseases; medical research services relating to kidney, heart, and liver health; research and development services in the field of antibodies relating to kidney, heart, and liver health; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; providing temporary use of on-line non-downloadable software and software applications for creating analytic and statistic models for data analysis in the field of kidney, heart, and liver health and kidney, heart, and liver disease
44 Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with kidney, heart, and liver health and kidney, heart, and liver disease
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
05. Juni 2023 2023/23 Gaz KR Ablehnung
27. Mai 2023 2023/22 Gaz NO Ablehnung
11. Mai 2023 2023/19 Gaz MX Ablehnung
08. Mai 2023 2023/19 Gaz IL Ablehnung
31. März 2023 2023/14 Gaz RU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
10. März 2023 2023/14 Gaz SG Ablehnung
10. März 2023 2023/11 Gaz CH Ablehnung
24. Februar 2023 2023/11 Gaz BR Ablehnung
16. Februar 2023 2023/7 Gaz JP Ablehnung
20. Dezember 2022 2022/51 Gaz CO Ablehnung
13. Dezember 2022 2022/50 Gaz NO Ablehnung
02. November 2022 2022/45 Gaz EM Ablehnung
12. Oktober 2022 2022/41 Gaz GB Ablehnung
06. September 2022 2022/38 Gaz IL Ablehnung
25. August 2022 2022/34 Gaz CN Ablehnung
13. August 2022 2022/34 Gaz NZ Ablehnung
05. August 2022 2022/32 Gaz RU Ablehnung
12. Juli 2022 2022/28 Gaz AU Ablehnung
17. Mai 2022 2022/22 Gaz IN Ablehnung
11. Januar 2022 2022/15 Gaz US Eintragung

ID: 141658287